151 related articles for article (PubMed ID: 15043662)
1. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease.
Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Sonobe T; Yanagawa H
Pediatr Int; 2004 Feb; 46(1):33-8. PubMed ID: 15043662
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of giant coronary aneurysms due to Kawasaki disease.
Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Yanagawa H
Pediatr Int; 2003 Aug; 45(4):410-3. PubMed ID: 12911476
[TBL] [Abstract][Full Text] [Related]
3. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.
Koyanagi H; Nakamura Y; Yanagawa H
Acta Paediatr; 1998 Jan; 87(1):32-6. PubMed ID: 9510444
[TBL] [Abstract][Full Text] [Related]
4. Giant coronary aneurysms due to Kawasaki disease: a case-control study.
Nakamura Y; Yashiro M; Oki I; Tanihara S; Ojima T; Yanagawa H
Pediatr Int; 2002 Jun; 44(3):254-8. PubMed ID: 11982891
[TBL] [Abstract][Full Text] [Related]
5. Six principal symptoms and coronary artery sequelae in Kawasaki disease.
Nakamura Y; Yashiro M; Sadakane A; Aoyama Y; Oki I; Uehara R; Yanagawa H
Pediatr Int; 2009 Oct; 51(5):705-8. PubMed ID: 19419505
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
[TBL] [Abstract][Full Text] [Related]
7. Giant coronary artery aneurysms in Kawasaki disease: the cost of a missed diagnosis.
Marta L; Francisco A; Anjos R
Cardiol Young; 2013 Aug; 23(4):608-9. PubMed ID: 23910022
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
[TBL] [Abstract][Full Text] [Related]
9. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children.
Garrido-García LM; Morán-Villaseñor E; Yamazaki-Nakashimada MA; Cravioto P; Galván F
Cardiol Young; 2018 Mar; 28(3):386-390. PubMed ID: 28847341
[TBL] [Abstract][Full Text] [Related]
10. [Kawasaki disease: heart disease during childhood].
Schroh AM; Domínguez P; Laghezza LB; Melonari PA; Olguín M; Miatello R
Rev Esp Cardiol; 2006 Apr; 59(4):387-90. PubMed ID: 16709393
[TBL] [Abstract][Full Text] [Related]
11. Flying with giant coronary aneurysms caused by Kawasaki disease.
Teramachi Y; Suda K; Ogawa S; Kamiyama H; Hamaoka K
Int J Cardiol; 2013 Oct; 168(5):4964-5. PubMed ID: 23916775
[No Abstract] [Full Text] [Related]
12. Factors related to cardiac sequelae of Kawasaki disease.
Zhang T; Yanagawa H; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
Eur J Pediatr; 1999 Sep; 158(9):694-7. PubMed ID: 10485297
[TBL] [Abstract][Full Text] [Related]
13. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications.
Sawaji Y; Haneda N; Yamaguchi S; Kajino Y; Kishida K; Seto S; Konishi N; Waki K; Baba K; Arisawa K; Kamiya T; Mori C
Acta Paediatr Jpn; 1998 Jun; 40(3):218-25. PubMed ID: 9695293
[TBL] [Abstract][Full Text] [Related]
14. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease.
Tsuda E; Hamaoka K; Suzuki H; Sakazaki H; Murakami Y; Nakagawa M; Takasugi H; Yoshibayashi M
Am Heart J; 2014 Feb; 167(2):249-58. PubMed ID: 24439987
[TBL] [Abstract][Full Text] [Related]
15. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.
Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T
J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055
[TBL] [Abstract][Full Text] [Related]
16. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease.
Daniels SR; Specker B; Capannari TE; Schwartz DC; Burke MJ; Kaplan S
Am J Dis Child; 1987 Feb; 141(2):205-7. PubMed ID: 3812389
[TBL] [Abstract][Full Text] [Related]
17. [Predicting value of thrombospondin-2 for coronary artery dilatation in patients with Kawasaki disease].
Song RX; Li XH; Zhang T; Cui XD; Fu J
Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):259-63. PubMed ID: 27055423
[TBL] [Abstract][Full Text] [Related]
18. Nationwide Survey of Patients With Giant Coronary Aneurysm Secondary to Kawasaki Disease 1999-2010 in Japan.
Fukazawa R; Kobayashi T; Mikami M; Saji T; Hamaoka K; Kato H; Suzuki H; Tsuda E; Ayusawa M; Miura M; Ebata R; Kobayashi T; Yashiro M; Ogawa S
Circ J; 2017 Dec; 82(1):239-246. PubMed ID: 28855435
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive evaluation of a patient with Kawasaki disease and giant coronary aneurysms with cardiac magnetic resonance.
Prsa M; Hussain T; McCrindle BW; Grosse-Wortmann L
Congenit Heart Dis; 2014; 9(6):E195-8. PubMed ID: 23948020
[TBL] [Abstract][Full Text] [Related]
20. Prediction of responsiveness or non-responsiveness to treatment of acute Kawasaki disease using 1 gram per kilogram of immunoglobulin--an effective and cost-saving schedule of therapy.
Ichihashi K; Shiraishi H; Momoi M
Cardiol Young; 2009 Jun; 19(3):224-7. PubMed ID: 19272202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
